Real-time SEC alerts Start Free →
Profitelligence
Zoetis Inc.
ZTS LOW Impact

Zoetis Inc.

Zoetis Inc. to Host Innovation Webcast on December 2, 2025

| 8-K |Healthcare

Summary

On December 2, 2025, Zoetis Inc. announced it will host an Innovation Webcast at 8:30 a.m. ET, discussing the shaping of the next era in animal health, focusing on market opportunity, proven innovation model, robust pipeline, and driving value. A presentation for the webcast is attached as Exhibit 99.1.

Profitelligence Profitelligence Alerts

Get alerts for ZTS

Be first to know when Zoetis Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Corporate Update Exhibits Furnished

Advertisement

About Zoetis Inc.

Zoetis Inc. is a global leader in the animal healthcare sector, specializing in the development, manufacture, and commercialization of a diverse range of medicines and vaccines for pets and livestock. Originally part of Pfizer, Zoetis spun off in 2013 and has solidified its position as a key player in the industry. The company's portfolio includes products aimed at veterinarians and livestock producers, supporting health and productivity across various animal species. Zoetis's impact is significant in both the companion animal market, which is driven by increasing pet ownership and rising expenditure on pet care, and the livestock market, which benefits from enhancements in productivity and disease management. Zoetis operates in over 100 countries, continuously investing in research and innovation to address the evolving needs of animal health. Its strategic initiatives and partnerships contribute to building a sustainable future for the animal health industry, bolstering Zoetis’s reputation and relevance in the global market.

Exchange: NYSE Industry: Drug Manufacturers - Specialty & Generic Company Website →

Official SEC Documents

ZTS
ZTS Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement